Citation tools
"Combined 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy and Platinum-Based Chemotherapy in Recurrent, Metastatic Sinonasal Neuroendocrine Carcinoma: A Promising Therapeutic Option." Journal of Nuclear Medicine Technology
48.3
(2020):
292-294.
Web. 13 May. 2025.